Genenta Science Enters Into Binding Offer With Sòphia High Tech For €6M Through Two Reserved Capital Increases, With The Goal Of Reaching Controlling Stake Upon The Achievement Of Defined Performance Milestones
3/27/2026
Impact: 50
Healthcare
Genenta Science S.p.A. (NASDAQ: GNTA) has entered into a binding offer to invest €6 million in Sòphia High Tech through two reserved capital increases, aiming for a controlling stake contingent on performance milestones. Sòphia High Tech, a manufacturer for Europe's aerospace and defense sectors, is projecting revenue growth and is already profitable, with plans to scale production and enhance technological capabilities. The transaction is subject to due diligence and necessary approvals, and the funds will be used to strengthen Sòphia's market position and production capacity.
AI summary, not financial advice
Share: